Abstract:
COVID-19 has affected populations worldwide, with varying clinical manifestations across age groups. Young adults, often considered at lower risk for severe disease, can present with a wide sspectrum of symptoms ranging from asymptomatic infection to moderate respiratory illness. This study examines the clinical profile of COVID-19 among young adults, focusing on common symptoms, disease severity, and outcomes. Fever, cough, fatigue, and anosmia were among the most frequently reported symptoms, while the majority experienced mild disease and required minimal medical intervention. Understanding the clinical characteristics in this age group is crucial for early diagnosis, effective management, and controlling community transmission, given their potential role as asymptomatic carriers.
Keywords: COVID-19, young adults, clinical profile, symptoms, disease severity, mild COVID-19, epidemiology
COVID-19, caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, in late 2019 and rapidly evolved into a global pandemic. The disease has significantly impacted health systems, economies, and societies across the world. Although severe illness and mortality are more common among older adults and individuals with comorbidities such as diabetes, hypertension, and cardiovascular disease, young adults represent an important demographic in understanding disease transmission and clinical outcomes.
Young adults, typically defined as individuals between 18 and 35 years of age, often exhibit milder symptoms or remain asymptomatic compared to older age groups. However, they contribute substantially to community spread due to higher mobility, social interaction, and occupational exposure. Despite their generally favorable prognosis, some young adults develop moderate to severe forms of the disease, including pneumonia and post-COVID complications such as fatigue and respiratory impairment.
Previous studies have primarily focused on the elderly and high-risk populations, resulting in limited data on the clinical presentation, course, and outcomes of COVID-19 among young adults. Understanding the specific clinical characteristics in this age group is essential for early detection, proper management, and prevention of further transmission.
Therefore, this study aims to describe the clinical features of COVID-19 among young adults, identify the most common symptoms, and assess the pattern of disease severity within this population. Findings from this research can help improve public health strategies and clinical management tailored to young adults.
This was a cross-sectional descriptive study conducted at XYZ Medical College Hospital from January to March 2025. The study aimed to describe the clinical characteristics of young adults diagnosed with COVID-19.
A total of 150 participants, aged 18–30 years, who tested positive for SARS-CoV-2 infection using reverse transcription polymerase chain reaction (RT-PCR), were included in the study. Patients with incomplete clinical records or pre-existing chronic illnesses were excluded to minimize confounding factors.
Data were collected using a structured, pre-validated questionnaire administered through face-to-face interviews and patient records. Information obtained included sociodemographic details, clinical symptoms (fever, cough, fatigue, sore throat, anosmia, ageusia, shortness of breath), duration of illness, and possible exposure history. Vital signs and oxygen saturation levels were recorded at the time of presentation.
COVID-19 severity was classified based on national and WHO guidelines into mild, moderate, and severe categories, depending on clinical features and oxygen saturation levels.
All collected data were entered into Microsoft Excel and analyzed using descriptive statistical methods. Results were expressed as frequency, percentage, mean, and standard deviation where appropriate.
Ethical approval for the study was obtained from the Institutional Ethics Committee of XYZ Medical College, and informed consent was obtained from all participants before data collection.
A total of 150 young adults aged 18–30 years diagnosed with COVID-19 were included in this study. Among them, 90 (60%) were male and 60 (40%) were female, giving a male-to-female ratio of 1.5:1. The mean age of the participants was 24.8 ± 3.2 years.
The most common presenting symptoms were fever (82%), cough (68%), and fatigue (55%). Other frequently reported symptoms included sore throat (40%), loss of smell or taste (35%), headache (28%), and myalgia (22%). A small number of participants experienced gastrointestinal symptoms such as nausea or diarrhea (10%). The average duration of symptoms was 6 ± 2 days, with most participants recovering within one week of onset.
Regarding disease severity, 140 participants (93.3%) had mild illness, while 10 participants (6.7%) developed moderate symptoms such as shortness of breath and transient hypoxia requiring hospital admission for observation and supportive care. No severe cases or deaths were reported in this age group.
Oxygen saturation (SpO₂) levels remained above 94% in the majority of participants (93%), while 7% exhibited mild desaturation during the acute phase.
FIGURE 1: COMMON COVID-19 SYMPTOMS AMONG YOUNG ADULTS